W Klapper
Overview
Explore the profile of W Klapper including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
82
Citations
1385
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brockelmann P, Muller H, Fuchs M, Gillessen S, Eichenauer D, Borchmann S, et al.
Ann Oncol
. 2024 Dec;
PMID: 39706337
Background: This study aimed to evaluate the correlation between progression-free (PFS) and overall survival (OS) after first-line treatment of classical Hodgkin lymphoma (HL) and to assess the potential of PFS...
2.
Garces de Los Fayos Alonso I, Zujo L, Wiest I, Kodajova P, Timelthaler G, Edtmayer S, et al.
Mol Cancer
. 2022 Aug;
21(1):172.
PMID: 36045346
Background: Anaplastic large cell lymphoma (ALCL) is an aggressive non-Hodgkin T cell lymphoma commonly driven by NPM-ALK. AP-1 transcription factors, cJUN and JUNb, act as downstream effectors of NPM-ALK and...
3.
Croci G, Au-Yeung R, Reinke S, Staiger A, Koch K, Oschlies I, et al.
Ann Oncol
. 2021 Aug;
32(11):1400-1409.
PMID: 34438040
Background: Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease with respect to outcome. Features of the tumor microenvironment (TME) are associated with prognosis when assessed by gene expression profiling....
4.
Pouyiourou M, Meyer A, Stroux A, Viardot A, La Rosee P, Maschmeyer G, et al.
Ann Hematol
. 2020 Aug;
99(12):2821-2829.
PMID: 32734548
Based on centroblast frequency, follicular lymphoma (FL) is subdivided into grades 1-2, 3A, and 3B. Grade FL3A frequently coexists with FL1-2 (FL1-2-3A). Based on clinical trials, FL1-2 is treated with...
5.
Koch K, Reddemann K, Klapper W, Oschlies I
Pathologe
. 2019 Apr;
40(4):412-421.
PMID: 30941488
Background: Several hematological malignancies might morphologically present as differential diagnoses of sarcomas. Objectives: To illustrate entities of hematological malignancies that might cause difficulties in differentiation from sarcomas and to introduce...
6.
Kurch L, Hasenclever D, Kluge R, Georgi T, Tchavdarova L, Golombeck M, et al.
Pediatr Blood Cancer
. 2018 Nov;
66(3):e27539.
PMID: 30426671
Purpose: In 2014, we published the qPET method to quantify fluorodeoxyglucose positron emission tomography (FDG-PET) responses. Analysis of the distribution of the quantified signals suggested that a clearly abnormal FDG-PET...
7.
Thiesen I, Wehkamp U, Bruggemann M, Ritgen M, Murga Penas E, Klapper W, et al.
Br J Dermatol
. 2018 Sep;
180(1):227-228.
PMID: 30183072
No abstract available.
8.
[Revised version of the 4th edition of the WHO classification of malignant lymphomas : What is new?]
Ott G, Klapper W, Feller A, Hansmann M, Moller P, STEIN H, et al.
Pathologe
. 2018 Jul;
40(2):157-168.
PMID: 30019203
After 8 years, the WHO has now published the updated version of the 4th edition of the classification of hematopoietic and lymphoid tumors. This update provides a conceptual rewrite of...
9.
Klapper W, Fend F, Feller A, Hansmann M, Moller P, STEIN H, et al.
Pathologe
. 2018 Apr;
40(2):152-156.
PMID: 29666909
The update of the 4th edition of the WHO classification for hematopoietic neoplasms introduces changes in the field of mature aggressive B‑cell lymphomas that are relevant to diagnostic pathologists. In...
10.
Altenbuchinger M, Schwarzfischer P, Rehberg T, Reinders J, Kohler C, Gronwald W, et al.
Bioinformatics
. 2017 Sep;
33(17):2790.
PMID: 28903540
No abstract available.